ezogabine has been researched along with haloperidol in 3 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 20,330 | 1,753 | 3,294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikkelsen, JD | 1 |
| Ebbesen, C; Hansen, HH; Mathiesen, C; Mikkelsen, JD; Rønn, LC; Scuvée-Moreau, J; Seutin, V; Waroux, O; Weikop, P | 1 |
| Hansen, HH; Mikkelsen, JD; Mikkelsen, MD; Rode, F; Weikop, P | 1 |
3 other study(ies) available for ezogabine and haloperidol
| Article | Year |
|---|---|
The KCNQ channel activator retigabine blocks haloperidol-induced c-Fos expression in the striatum of the rat.
Topics: Animals; Anticonvulsants; Carbamates; Cell Count; Corpus Striatum; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Gene Expression Regulation; Haloperidol; Immunohistochemistry; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Phenylenediamines; Potassium Channels; Potassium Channels, Voltage-Gated; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar | 2004 |
The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.
Topics: Animals; Anthracenes; Carbamates; Dopamine; Dopamine Antagonists; Haloperidol; KCNQ Potassium Channels; Male; Mesencephalon; Phenylenediamines; Phosphorylation; Protein Subunits; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2006 |
The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
Topics: Animals; Anticonvulsants; Biomarkers; Carbamates; Corpus Striatum; Cortical Excitability; Dopamine Antagonists; Drug Interactions; Gene Expression Regulation; Haloperidol; Injections, Intraventricular; KCNQ Potassium Channels; Male; Membrane Transport Modulators; Nerve Tissue Proteins; Neurons, Afferent; Neurons, Efferent; Nucleus Accumbens; Phenylenediamines; Protein Subunits; Proto-Oncogene Proteins c-fos; Rats, Wistar; Synaptic Transmission | 2017 |